Literature DB >> 9694794

Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression.

E S Knudsen1, C Buckmaster, T T Chen, J R Feramisco, J Y Wang.   

Abstract

The retinoblastoma tumor suppressor protein, RB, is a negative regulator of cell proliferation. Growth inhibitory activity of RB is attenuated by phosphorylation. Mutation of a combination of phosphorylation sites leads to a constitutively active RB. In Rat-1 cells, the phosphorylation-site-mutated (PSM)-RB, but not wild-type RB, can inhibit S-phase entry. In PSM-RB-arrested G1 cells, normal levels of cyclin E and cyclin E-associated kinase activity were detected, but the expression of cyclin A was inhibited. The ectopic expression of cyclin E restored cyclin A expression and drove the PSM-RB expressing cells into S phase. Interestingly, Rat-1 cells coexpressing cyclin E and PSM-RB could not complete DNA replication. Microinjection of cells that have passed through the G1 restriction point with plasmids expressing PSM-RB also led to the inhibition of DNA synthesis. The S-phase inhibitory activity of PSM-RB could be attenuated by the coinjection of SV40 T-antigen, adenovirus E1A, or a high level of E2F-1 expression plasmids. However, the S-phase inhibitory activity of PSM-RB could not be overcome by the coinjection of cyclin E or cyclin A expression plasmids. These results reveal a novel role for RB in the inhibition of S-phase progression that is distinct from the inhibition of the G1/S transition, and suggest that continued phosphorylation of RB beyond G1/S is required for the completion of DNA replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694794      PMCID: PMC317048          DOI: 10.1101/gad.12.15.2278

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  55 in total

1.  Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases.

Authors:  T Zarkowska; S Mittnacht
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

2.  Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.

Authors:  E S Knudsen; J Y Wang
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.

Authors:  K Alevizopoulos; J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

4.  Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.

Authors:  A S Lundberg; R A Weinberg
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

Review 5.  The retinoblastoma protein pathway in cell cycle control and cancer.

Authors:  J Bartek; J Bartkova; J Lukas
Journal:  Exp Cell Res       Date:  1997-11-25       Impact factor: 3.905

Review 6.  Recent insights into the functions of the retinoblastoma susceptibility gene product.

Authors:  W G Kaelin
Journal:  Cancer Invest       Date:  1997       Impact factor: 2.176

7.  pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.

Authors:  R K Hurford; D Cobrinik; M H Lee; N Dyson
Journal:  Genes Dev       Date:  1997-06-01       Impact factor: 11.361

8.  Retinoblastoma protein represses transcription by recruiting a histone deacetylase.

Authors:  L Magnaghi-Jaulin; R Groisman; I Naguibneva; P Robin; S Lorain; J P Le Villain; F Troalen; D Trouche; A Harel-Bellan
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

9.  Retinoblastoma protein recruits histone deacetylase to repress transcription.

Authors:  A Brehm; E A Miska; D J McCance; J L Reid; A J Bannister; T Kouzarides
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

10.  Cyclin E-induced S phase without activation of the pRb/E2F pathway.

Authors:  J Lukas; T Herzinger; K Hansen; M C Moroni; D Resnitzky; K Helin; S I Reed; J Bartek
Journal:  Genes Dev       Date:  1997-06-01       Impact factor: 11.361

View more
  78 in total

1.  Accumulation of cyclin E is not a prerequisite for passage through the restriction point.

Authors:  S V Ekholm; P Zickert; S I Reed; A Zetterberg
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  Clink, a nanovirus-encoded protein, binds both pRB and SKP1.

Authors:  M N Aronson; A D Meyer; J Györgyey; L Katul; H J Vetten; B Gronenborn; T Timchenko
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 3.  Cell cycle checkpoints as therapeutic targets.

Authors:  Z A Stewart; J A Pietenpol
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

4.  Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.

Authors:  E Santoni-Rugiu; J Falck; N Mailand; J Bartek; J Lukas
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

5.  Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.

Authors:  F A Dick; E Sailhamer; N J Dyson
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

6.  Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function.

Authors:  T T Chen; J Y Wang
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells.

Authors:  D Chattopadhyay; M K Ghosh; A Mal; M L Harter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.

Authors:  Z Sever-Chroneos; S P Angus; A F Fribourg; H Wan; I Todorov; K E Knudsen; E S Knudsen
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

9.  Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice.

Authors:  Alain de Bruin; Lizhao Wu; Harold I Saavedra; Pamela Wilson; Ying Yang; Thomas J Rosol; Michael Weinstein; Michael L Robinson; Gustavo Leone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

10.  Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice.

Authors:  Feng X Li; Jing W Zhu; Christopher J Hogan; James DeGregori
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.